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doi:10.1016/j.jtcvs.2006.05.026arlier this year I attended the Cardiovascular Conference at Snowmass,
Colorado, one of the longest running cardiology postgraduate courses (ap-
proximately 37 years), which brings together thought leaders in the various
reas of acquired heart disease. I came away from this meeting very impressed that
ardiologists worldwide are deriving an increasing amount of what they apply to
heir practice and care of their patients from evidence-based cardiology studies.
pproximately 100 prospective randomized studies, mostly related to coronary
rtery disease, were discussed during that week, with enough study acronyms to test
he most agile thinker. I reflected on this and wondered, (1) what are we doing in
ardiac surgery to validate many of the applications we believe are the best
echniques and therapies for patients, and (2) do we fully understand that our
edical counterparts are basing their therapy for patients, including surgical ther-
py, on these evidenced-based studies?
Clearly, coronary artery bypass surgery has been reviewed in many of these
rials. Recent studies from database outcomes strongly suggest that coronary artery
ypass grafting (CABG) should be more frequently used than stent placement
nasmuch as CABG is associated with fewer long-term morbid events than coronary
tenting.1,2 But when it comes to comparison of different forms of commonly used
urgical techniques and technologies for valve surgery, arrhythmic surgery, and
eart failure, there is a paucity of evidence-based trials. At that same meeting in
anuary, I presented data from the Brigham and Women’s Hospital related to
hybrid” therapy for combined aortic valve and coronary disease in high-risk,
lderly individuals: an elective, minimally invasive aortic valve replacement per-
ormed after a percutaneous coronary intervention in the morning for moderate
oronary disease with the intent to decrease operation time and trauma. Clearly, this
s a pilot study for feasibility, safety, and effectiveness, but the first question I
eceived from the audience was, “Have you done a prospective randomized study
alidating this therapy against the standard form of therapy with a full sternotomy
nd combined aortic valve replacement and coronary artery bypass surgery?”
Not only should cardiovascular surgeons focus more on evidence-based studies,
articularly for areas clearly controversial, but we also should be leading the way in
rganization and performance of these studies. One of the few prospective random-
zed valve surgery studies that has shaped my practice is the one by Cohen and
ssociates,3 who, in a prospective randomized study, demonstrated that stentless
ersus stented bioprosthetic valves offered no advantage in mortality, left ventric-
lar remodeling, or reduction of left ventricular masses. Similarly, the REMATCH
Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive
eart Failure) trial,4 a very important evidence-based study, one of a very few in the
rea of heart failure, demonstrated that therapy with a left ventricular assist device
s better than medical therapy for end-stage heart failure.
I believe we need to be proactive in many areas of investigation. Lately, some in
ur specialty have been lamenting about the reduction of caseload and referral of
atients to medical and interventional therapy, without really understanding the
indset of our cardiology colleagues. We have to be more aggressive in promoting
tudies to prove which surgical therapies are the best therapies so that we not only
ompete with our cardiologic colleagues, but demonstrate to an increasingly in-
ormed patient population that there is evidence demonstrating one surgical tech-
ology is better than another.
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LMany examples of knowledge gaps exist. One glaring
xample that clearly needs clarification is the surgical treat-
ent of atrial fibrillation. There is need for multiple studies
n a prospective randomized basis to review catheter tech-
iques versus the new surgical techniques, technology ver-
us technology, to determine success rate and reproduc-
bility of minimally invasive techniques versus standard
urgical therapy. Even ablation of the left atrial appendage
as yet to be studied in a prospective manner. We (and that
ncludes cardiologists) cannot even agree on what “success”
s after atrial fibrillation procedures. If we do not perform
hese studies, I am concerned that payors may doubt the
alidity of certain procedures and may request these studies
r perhaps label them experimental.
As noted, many surgeons are also talking about “hybrid”
herapy and building operating suites to perform combined
ABG/valve procedures with minimally invasive methods.
e need to validate these approaches. We need more crit-
cal studies on heart failure devices, especially with cardiac
efibrillators and ventricular resection,2 and we need more
tudies related to off-pump versus on-pump CABG.
The increasing use of clinical outcomes databases (such
s The Society of Thoracic Surgeons database) by cardiac
urgeons can be leveraged to suggest the most fruitful areas
or prospective analysis. The National Institutes of Health
nd other funding nonprofit organizations are the preferred
athways for these studies. At the recent meeting of The
58 The Journal of Thoracic and Cardiovascular Surgery ● Septemerican Association for Thoracic Surgery, the National In-
titutes of Health, recognizing the need for more evidence-
ased surgical studies, convened a request for proposal for
he establishment of a cardiac surgical research and out-
omes network. More than 30 hospital-based units appeared
t the orientation and information session eager to par-
icipate. Finally, we must understand the American Heart
ssociation/American College of Cardiology cardiac dis-
ase guidelines, such as the soon-to-be released valvular
eart disease guidelines complied after an exhaustive meta-
nalysis of worldwide valve disease literature.
I think we as an aggressive, intelligent community of
ardiovascular specialists can and should find ways to de-
ermine our future and the future care of our patients in a
uch more critical and evidence-based manner.
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